Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11168128
Antibodies against SARS-CoV-2 and methods of using the same
granted -
US 11168146
Compositions and methods for increasing protein half-life in a serum
granted -
US 11168071
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted -
US 11167041
Adeno-associated virus variant capsids and methods of use thereof
granted -
US 11168091
Quantification and preparation of pharmaceutical grade cantharidin
granted -
US 11168082
Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors
granted -
US 11167012
Peptide inhibition of CCR3-mediated diseases or conditions
granted -
US 11168111
Readily isolated bispecific antibodies with native immunoglobulin format
granted -
US 11167004
Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
granted -
US 11166985
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11166976
S-antigen transport inhibiting oligonucleotide polymers and methods
granted -
US 11166990
Methods and compositions for treating ulcerative colitis
granted -
US 11166972
Compositions comprising nicotinamide riboside and a urolithin
granted -
US 11166957
Antiviral prodrugs and nanoformulations thereof
granted -
US 11166949
NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic
granted -
US 11166960
Modified release preparations containing oxcarbazepine and derivatives thereof
granted -
US 11166962
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11166963
Natural combination hormone replacement formulations and therapies
granted -
US 11166924
N-methyl-d-aspartate receptor allosteric modulators and methods for their use
granted -
US 11166929
Fatty-acid based particles
granted -
US 11166906
Programmable pharmaceutical compositions for chrono drug release
granted -
WO 2021219719
PROCÉDÉS DE RADIOMARQUAGE DE LIGANDS SE LIANT AU PSMA ET LEURS KITS
granted -
WO 2021219720
PROCÉDÉS DE RADIOMARQUAGE DE LIGANDS DE LIAISON PSMA ET LEURS KITS
granted -
US 2021338651
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.